Michael D. Ezekowitz

Also affiliated with Lankenau Institute for Medical Research, Lankenau Heart Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “Dabigatran versus Warfarin in Patients with Atrial Fibrillation”.

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine(2009)10.1056/nejmoa0905561

N/A

1.4DataRank · unranked

11147 citations

Michael D. Ezekowitz, Salim Yusuf, John Eikelboom, Jonas Oldgren, Amit Parekh +20 more

Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation

Circulation(2010)10.1161/circulationaha.110.973735

N/A

0.771DataRank · unranked

170 citations

Lars Wallentin, Stuart J. Connolly, Amit Parekh, Michael R. Chernick, Janice Pogue +6 more

Drug Interactions Affecting Oral Anticoagulant Use

Circulation Arrhythmia and Electrophysiology(2022)10.1161/circep.121.007956

N/A

0.683DataRank · unranked

94 citations

Rakesh Gopinathannair, Brooke Gengler, Mina K. Chung, Arturo Perez, Jonathan W. Dukes +9 more

Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions

European Heart Journal - Quality of Care and Clinical Outcomes(2020)10.1093/ehjqcco/qcaa040

N/A

0.557DataRank · unranked

40 citations

Karen S. Pieper, Rebecca North, Larry A. Allen, Paul S. Chan, Michael D. Ezekowitz +15 more

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas

Open Heart(2021)10.1136/openhrt-2020-001471

N/A

0.555DataRank · unranked

12 citations

Ziad Hijazi, Johan Lindbäck, John H. Alexander, M. Cecilia Bahit, Raffaele De Caterina +9 more

LVS‐HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World‐Wide Registry

Journal of the American Heart Association(2021)10.1161/jaha.120.017735

N/A

0.345DataRank · unranked

9 citations

Jonas Oldgren, Tyler W. Barrett, Candace D. McNaughton, Jorge Wong, William F. McIntyre +12 more

Drug Interactions Affecting Antiarrhythmic Drug Use

Circulation Arrhythmia and Electrophysiology(2022)10.1161/circep.121.007955

N/A

0DataRank · unranked

31 citations

Piotr Horbal, Mina K. Chung, Jonathan W. Dukes, Michael D. Ezekowitz, Dhanunjaya Lakkireddy +8 more

Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation

American Heart Journal(2020)10.1016/j.ahj.2020.01.001

N/A

0DataRank · unranked

32 citations

Rebecca North, Karen S. Pieper, Gregg C. Fonarow, Peter R. Kowey, Bernard J. Gersh +12 more

Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation

Heart Rhythm O2(2022)10.1016/j.hroo.2022.09.018

N/A

0DataRank · unranked

10 citations

Peter Shrader, Marat Fudim, Karen S. Pieper, Rosalia Blanco, Gregg C. Fonarow +14 more

Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials

Circulation Cardiovascular Quality and Outcomes(2024)10.1161/circoutcomes.123.010269

N/A

0DataRank · unranked

10 citations

Carl van Walraven, Sun Young Jeon, W. John Boscardin, Richard Hobbs, Stuart J. Connolly +5 more